Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gil Awada

13PUBLICATIONS
18CO-AUTHORS
NanomedicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Oct 07, 2024
Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated <i>BRAF</i><sup><i>V600</i></sup><i>/NRAS</i><sup><i>Q61</i></sup> Wild-Type Melanoma (TraMel-WT).

Gil Awada, Iris Dirven, Julia Katharina Schwarze

|Feb 11, 2023
Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study.

Giuseppe Fasolino, Gil Awada, Laura Moschetta

|Sep 16, 2022
Intratumoral administration of CD1c (BDCA-1)<sup>+</sup> and CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial.

Julia Katharina Schwarze, Jens Tijtgat, Gil Awada

|Mar 29, 2022
Anti-PD-1: When to Stop Treatment.

Y Jansen, A A M van der Veldt, G Awada

|Feb 15, 2022
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial.

Julia Katharina Schwarze, Soizic Garaud, Yanina J L Jansen

|Jun 25, 2021
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial.

Johnny Duerinck, Julia Katharina Schwarze, Gil Awada

Pageof 3

Frequent Collaborators

11 joint publications

Bart Neyns

8 joint publications

Julia Katharina Schwarze

3 joint publications

Yanina Jansen

3 joint publications

Jens Tijtgat

2 joint publications

Anne Rogiers

2 joint publications

Marleen Keyaerts

1 joint publications

A A M van der Veldt

1 joint publications

Jennifer De Cremer

1 joint publications

Peter Theuns

1 joint publications

Mark De Ridder

Frequent Collaborators

11 joint publications

Bart Neyns

8 joint publications

Julia Katharina Schwarze

3 joint publications

Yanina Jansen

3 joint publications

Jens Tijtgat

Top Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.3K
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on : Mar 12, 2022

3.7K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.5K
See more related videos

Top Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

12.3K
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
12:28

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on : Mar 12, 2022

3.7K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.5K
See more related videos